Deepak Vadehra (@deebacca) 's Twitter Profile
Deepak Vadehra

@deebacca

GI Medical Oncologist @roswellpark focusing on lower GI malignancies. Colorectal Cancer researcher and working to improve research in young onset CRC.

ID: 43406999

calendar_today29-05-2009 20:52:11

146 Tweet

192 Followers

146 Following

Gut Onc Lab (@thegutonclab) 's Twitter Profile Photo

We are growing!!! Love our biweekly lab meetings and all the cool ideas/collaborations. We are also trying to match Deepak Vadehra’s background game; guess we will get there one day. Watch this space for more 🚀 🔥 Tim Brown, MD MSCE Nicholas Hornstein Udhayvir Grewal Brandon Rose, MD, MPH Sawyer Bawek, DO

We are growing!!! Love our biweekly lab meetings and all the cool ideas/collaborations.
We are also trying to match <a href="/Deebacca/">Deepak Vadehra</a>’s background game; guess we will get there one day. 
Watch this space for more 🚀 🔥
<a href="/TimothyJBrownMD/">Tim Brown, MD MSCE</a> <a href="/GIMedOnc/">Nicholas Hornstein</a> <a href="/UGrewalMD/">Udhayvir Grewal</a> <a href="/BRoseMDMPH/">Brandon Rose, MD, MPH</a> <a href="/sawyer_bawek/">Sawyer Bawek, DO</a>
Nicholas Hornstein (@gimedonc) 's Twitter Profile Photo

💥New paper out! We reanalyzed raw sequencing data from 18,558 standard-of-care Guardant360 ctDNA assays in advanced #colorectalcancer using a partner-agnostic fusion caller. 🧬 Fusions in 1.3% of patients 🧪 93% were subclonal — enriched after EGFR therapy 🔗 Clonal fusions

Nicholas Hornstein (@gimedonc) 's Twitter Profile Photo

Another new paper out! Grateful to have been a part of the effort. We (Andrew Pellatt and Arvind Dasari) asked: Can TAS-102 eliminate ctDNA-defined MRD in CRC after adjuvant chemo? 💊 Single-arm phase II study of CRC pts with MRD by ctDNA after curative-intent therapy (Stage

The Oncologist (@oncjournal) 's Twitter Profile Photo

Drs Udhayvir Grewal and Tim Brown, MD MSCE discuss the evolving treatment of #stmcsm with new targeted agents 🎯like zolbetuximab for #HER2- but #CLDN182+ disease. They describe 4 biomarker (MSI/MMR, HER2, PD-L1, CLDN18.2) profiles that guide therapy #GIonc doi.org/10.1093/oncolo…

Drs <a href="/UGrewalMD/">Udhayvir Grewal</a> and <a href="/TimothyJBrownMD/">Tim Brown, MD MSCE</a> discuss the evolving treatment of #stmcsm with new targeted agents 🎯like zolbetuximab for #HER2- but #CLDN182+ disease. They describe 4 biomarker (MSI/MMR, HER2, PD-L1, CLDN18.2) profiles that guide therapy #GIonc
doi.org/10.1093/oncolo…
Sarbajit Mukherjee (@sarbaji85064063) 's Twitter Profile Photo

Had a great time at the We Stand Together Health & Wellness Fair this weekend! Really appreciated the chance to talk with community members about colorectal cancer—so many great questions and conversations. Baptist Health Baptist Health Cancer Care #ColorectalCancer #CancerAwareness

Had a great time at the We Stand Together Health &amp; Wellness Fair this weekend! Really appreciated the chance to talk with community members about colorectal cancer—so many great questions and conversations. <a href="/BaptistHealthSF/">Baptist Health</a> <a href="/BHCancerCare/">Baptist Health Cancer Care</a> #ColorectalCancer #CancerAwareness
Nicholas Hornstein (@gimedonc) 's Twitter Profile Photo

CEA was discovered in 1965. By the 1970s, CEACAM5 was recognized as a hallmark of colorectal cancer. Yet in 2025, CRC still has no approved ADCs. That may change. 🚨 First-in-human data for Precem-TcT (anti-CEACAM5 + exatecan) now in Nature Medicine PROCEADE-CRC-01 dose

Dr. Cathy Eng (@cathyengmd) 's Twitter Profile Photo

Finally published The Oncologist: "Blueprint for creating an #earlyonset #colorectal #cancer program based on experiences from seven clinical centers across the United States and Canada" academic.oup.com/oncolo/article… #earlyonset #colorectal #cancer #cancerresearch Vanderbilt University Medical Center

Finally published <a href="/OncJournal/">The Oncologist</a>: "Blueprint for creating an #earlyonset #colorectal #cancer program based on experiences from seven clinical centers across the United States and Canada" academic.oup.com/oncolo/article… #earlyonset #colorectal #cancer #cancerresearch <a href="/VUMCDiscoveries/">Vanderbilt University Medical Center</a>
OncoDaily GI (@oncodailygi) 's Twitter Profile Photo

Hunting for the Very Rare Clonal Fusions for Clinical Benefit - Scott Kopetz oncodaily.com/science/scott-… Nicholas Hornstein #ColorectalCancer #CRC #EGFR #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

Hunting for the Very Rare Clonal Fusions for Clinical Benefit - <a href="/skopetz/">Scott Kopetz</a> 

oncodaily.com/science/scott-…

<a href="/GIMedOnc/">Nicholas Hornstein</a> 

#ColorectalCancer #CRC #EGFR  #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews
Scott Kopetz (@skopetz) 's Twitter Profile Photo

Targeting the YAP-SDC1 axis overcomes resistance to KRASi in GI cancers by blocking SDC1-driven macropinocytosis and RTK activation, offering a promising strategy for KRASi resistance. Wantong Yao Haoqiang Ying Cell Reports Medicine #crcsm To the clinic! pubmed.ncbi.nlm.nih.gov/40713971/

Targeting the YAP-SDC1 axis overcomes resistance to KRASi in GI cancers by blocking SDC1-driven macropinocytosis and RTK activation, offering a promising  strategy for KRASi resistance. <a href="/wantong_yao/">Wantong Yao</a> <a href="/HaoqiangY/">Haoqiang Ying</a> <a href="/CellRepMed/">Cell Reports Medicine</a> #crcsm To the clinic! pubmed.ncbi.nlm.nih.gov/40713971/
Nicholas Hornstein (@gimedonc) 's Twitter Profile Photo

Hot off the presses, probably my favorite interventional paper of 2025 (doesn't hurt that I look up to several of the authors as mentors or role models). 💉RAS vaccination is starting to look less like fantasy, more like reality. 🆕 Nature Medicine | Wainberg et al 🎯

Hot off the presses, probably my favorite interventional paper of 2025 (doesn't hurt that I look up to several of the authors as mentors or role models). 

💉RAS vaccination is starting to look less like fantasy, more like reality.

🆕 Nature Medicine | Wainberg et al
🎯
Udhayvir Grewal (@ugrewalmd) 's Twitter Profile Photo

Congratulatios Deepak Vadehra !! This is so amazing! Proud to know you and work with you. This is such important work for the care of young patients with cancer. #AYAsm

Deepak Vadehra (@deebacca) 's Twitter Profile Photo

I appreciate the shout out from my brothers at Gut Onc Lab. So much work to do , and just thrilled to be able to help contribute to moving the bar forward

Gut Onc Lab (@thegutonclab) 's Twitter Profile Photo

Excited to have the one and only Dr. Nina Niu Sanford join us for our lab meeting today. Exciting perspectives on some very cool GI Onc research ideas. Thanks for joining us, sharing your wisdom & offering some solid advice. The team is gearing up for #GI26 but mostly just having fun 🚀

Excited to have the one and only <a href="/NiuSanford/">Dr. Nina Niu Sanford</a> join us for our lab meeting today. Exciting perspectives on some very cool GI Onc research ideas. Thanks for joining us, sharing your wisdom &amp; offering some solid advice. 
The team is gearing up for #GI26 but mostly just having fun 🚀